TB
|
0.8
|
mg/dl
|
(0.4–1.2)
|
WBC
|
6000
|
/μl
|
(3600–8900)
|
AFP
|
1
|
ng/ml
|
(<20)
|
AST
|
17
|
U/L
|
(5–37)
|
Neutro
|
55.2
|
%
|
(37–72)
|
PIVKA-II
|
12
|
mAU/ml
|
(<40)
|
ALT
|
15
|
U/L
|
(6–43)
|
Lymph
|
37.6
|
%
|
(25–48)
|
CA19-9
|
<1
|
U/ml
|
(<35)
|
ALP
|
245
|
U/L
|
(110–348)
|
Mono
|
3.7
|
%
|
(2–12)
|
CA125
|
16
|
U/ml
|
(<37)
|
γGTP
|
13
|
U/L
|
(0–75)
|
Eosino
|
3.7
|
%
|
(1–9)
| | | | |
BUN
|
11.6
|
mg/dl
|
(9–21)
|
Baso
|
2.2
|
%
|
(0–2)
| | | | |
Cr
|
0.62
|
mg/dl
|
(0.5–0.8)
|
Hb
|
13.9
|
g/dl
|
(11.2–15.2)
| | | | |
| | | |
HCT
|
42
|
%
|
(35.6–45.4)
| | | | |
| | | |
Plt
|
2.43
|
106/μl
|
(1.53 - 3.46)
| | | | |
-
TB total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, gGTP γ glutamyl transpeptidase, BUN blood urea nitrogen, Cr creatinine, WBC white blood cell, Neutro neutrophil, Lymph lymphocyte, Mono monocyte, Eosino eosinophil, Baso basophil, Hb hemogrobin, HCT haematocrit, Plt platelet, AFP alpha‐fetoprotein, PIVKA-II protein induced by vitamin K absence or antagonist-II